Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicity
Open Access
- 4 March 2025
- journal article
- Published by Elsevier in Cell Genomics
- Vol. 5 (3) , 100783
Abstract
No abstract availableKeywords
Funding Information
- Japan Prize Foundation
- Moonshot Research and Development Program
- Japan Society for the Promotion of Science (23K14451)
- Japan Society for the Promotion of Science (22H00476)
- RIKEN
- Diabetes-Stiftung
- Osaka University
- Public Foundation of Vaccination Research Center
- Japan Agency for Medical Research and Development (JP21fk0108469)
- Japan Agency for Medical Research and Development (JP23fk0108686)
- Japan Agency for Medical Research and Development (JP24tm0524008)
- Japan Agency for Medical Research and Development (JP243fa627010)
- Japan Agency for Medical Research and Development (JP24gm1810011)
- Japan Agency for Medical Research and Development (JP24km0405217)
- Japan Agency for Medical Research and Development (JP243fa627002)
- Japan Agency for Medical Research and Development (JP24kk0305022)
- Japan Agency for Medical Research and Development (JP24tm0524002)
- Japan Agency for Medical Research and Development (JP24wm0625504)
- Japan Agency for Medical Research and Development (JP243fa627011)
- Japan Agency for Medical Research and Development (JP24ek0109594)
- Japan Agency for Medical Research and Development (JP24ek0410113)
- Japan Agency for Medical Research and Development (JP24zf0127008)
- Takeda Science Foundation
- Precursory Research for Embryonic Science and Technology (JPMJPR21R7)
- Precursory Research for Embryonic Science and Technology (JPMJPR22R2)
This publication has 57 references indexed in Scilit:
- Genetic determinants of IgG antibody response to COVID-19 vaccinationThe American Journal of Human Genetics, 2024
- Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccineVaccine, 2023
- Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 VariantsJournal of Clinical Immunology, 2022
- Overview of the BioBank Japan Project: Study design and profileJournal of Epidemiology, 2017
- Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to PathogensCell, 2016
- Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common VirusesThe American Journal of Human Genetics, 2015
- Complete Haplotype Sequence of the Human Immunoglobulin Heavy-Chain Variable, Diversity, and Joining Genes and Characterization of Allelic and Copy-Number VariationThe American Journal of Human Genetics, 2013
- Integrative genomics viewerNature Biotechnology, 2011
- A haplotype map of the human genomeNature, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004